Renergen Secures US$7mm Investment from Airsol

Renergen has raised a total of US$7mm from Airsol, a subsidiary of the SOL Group – an Italian company specialising in the production and research of medical gases, via unsecured convertible debentures. SOL originally subscribed for convertible debentures in Renergen for US$3mm. The remaining tranche of convertible debentures of US$4mm was subject to Renergen and Tetra4 implementing the recently announced transaction with Mahlako Gas. SOL’s investment and expertise in the industrial and helium gas sectors are set to bolster Renergen’s Virginia Gas Project. Both companies anticipate mutual benefits, with SOL expanding its helium access and Renergen leveraging technical and global industry partnerships, providing a strategic long-term collaboration.

Want to read more?

Subscribe to akapenergy.com to keep reading this exclusive post.

Subscribe Now